Evidence map›Paper›PMID 38517190›Full record

ArticleAntimicrobial agents and chemotherapy2024

A nanochitosan-D-galactose formulation increases the accumulation of primaquine in the liver.

F Gomes, A C Ribeiro, G S Sanches, H S Borges, L A U Takahashi, C T Daniel-Ribeiro, A C Tedesco, J W L Nascimento, L J M Carvalho

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

F Gomes *Laboratory of Malaria Research, Oswaldo Cruz Institute (IOC/Fiocruz), Reference Center for Malaria Research, Diagnosis and Training, Rio de Janeiro, Brazil.
A C Ribeiro *Laboratory of Malaria Research, Oswaldo Cruz Institute (IOC/Fiocruz), Reference Center for Malaria Research, Diagnosis and Training, Rio de Janeiro, Brazil.
G S SanchesLaboratory of Malaria Research, Oswaldo Cruz Institute (IOC/Fiocruz), Reference Center for Malaria Research, Diagnosis and Training, Rio de Janeiro, Brazil.
H S BorgesDepartment of Chemistry, Center of Nanotechnology and Tissue Engineering - Photobiology and Photomedicine Research Group, Faculty of Philosophy, Sciences and Letters, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
L A U TakahashiDepartment of Chemistry, Center of Nanotechnology and Tissue Engineering - Photobiology and Photomedicine Research Group, Faculty of Philosophy, Sciences and Letters, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
C T Daniel-RibeiroLaboratory of Malaria Research, Oswaldo Cruz Institute (IOC/Fiocruz), Reference Center for Malaria Research, Diagnosis and Training, Rio de Janeiro, Brazil.
A C TedescoDepartment of Chemistry, Center of Nanotechnology and Tissue Engineering - Photobiology and Photomedicine Research Group, Faculty of Philosophy, Sciences and Letters, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.ORCID 0000-0003-4198-9321
J W L NascimentoDepartment of Pharmacology (LaFaCE) - ICB, Federal University of Juiz de Fora (UFJF), Juiz de Fora, Minas Gerais, Brazil.
L J M CarvalhoLaboratory of Malaria Research, Oswaldo Cruz Institute (IOC/Fiocruz), Reference Center for Malaria Research, Diagnosis and Training, Rio de Janeiro, Brazil.ORCID 0000-0003-0133-6430
Fundação Oswaldo Cruz · BRUniversidade de São Paulo · BRUniversidade Federal de Juiz de Fora · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 304687/2021-9Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 316462/2021-7Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 404416/2021-7Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 441673/2020-1Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) E-26/200.314/2022Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG) APQ-03823-17Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) 2013/50181-1Fundação Oswaldo Cruz (FIOCRUZ) VPPIS-001-FIO-18-9
6 · The paper itself

Abstract

Primaquine is the mainstream antimalarial drug to prevent

Indexed as

AntimalarialsChitosanGalactoseLiverPrimaquineAnimalsMaleMiceNanoparticlesNanostructuresTissue DistributionAntimalarialsChitosanGalactosePrimaquineG6PD deficiencyliver deliverymalariananochitosannanostructureprimaquine

Identifiers

PMID38517190
PMCPMC11064505
OpenAlexW4393097043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.